Welcome to our dedicated page for Encore Energy SEC filings (Ticker: EU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The enCore Energy Corp. (EU) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, including current reports on Form 8‑K, quarterly reports on Form 10‑Q and annual reports on Form 10‑K. As a uranium company listed on The Nasdaq Capital Market and the TSX Venture Exchange, enCore uses these filings to report material events, financial results, executive appointments and key project developments.
Form 8‑K filings for enCore frequently cover management and board changes, such as the appointment of a Chief Executive Officer, Chief Financial Officer and other senior roles, as well as director resignations and new board appointments. They also describe compensatory arrangements, including employment agreements, severance terms and equity awards under long-term incentive plans.
Filings also document capital markets transactions, notably the company’s 5.50% Convertible Senior Notes due 2030. Related 8‑Ks outline the purchase agreement, indenture terms, conversion features, redemption provisions and associated capped call transactions, along with the intended use of proceeds and relationships to a uranium loan agreement.
Project-related disclosures appear in 8‑Ks that furnish press releases about the Dewey Burdock ISR Uranium Project’s inclusion in the FAST‑41 program and permitting milestones, as well as operational and financial updates from South Texas ISR operations. Quarterly reports on Form 10‑Q and annual reports on Form 10‑K, referenced in company news, contain consolidated financial statements, management’s discussion and analysis and risk factor discussions relevant to uranium extraction and ISR projects.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly identify items such as new financing arrangements, changes in executive compensation, or updates on ISR project permitting. Real-time integration with the SEC’s EDGAR system ensures that new EU filings, including Forms 3, 4 and 5 for insider transactions when available, are surfaced promptly so investors can review trading by directors and officers alongside broader corporate disclosures.
enCore Energy Corp. reported Q3 results reflecting early-stage uranium operations and investment activity. Revenue was $8.876 million, yielding gross profit of $3.891 million as cost of sales fell. Operating expenses of $17.931 million led to an operating loss of $14.040 million and a net loss attributable to enCore of $4.762 million ($0.03 per share). Year-to-date, revenue was $30.780 million with a net loss attributable to enCore of $35.331 million.
Liquidity strengthened: cash and cash equivalents were $91.933 million, supported by issuance of convertible senior notes recorded at $109.315 million and capped call premiums of $11.549 million. Total assets rose to $441.901 million, while total liabilities were $164.145 million. The company recorded positive realized and unrealized gains on marketable securities during the quarter. Sales commitments total 8.125 million pounds across future years. As of November 7, 2025, shares outstanding were 187,249,534. The Dewey-Burdock project advanced with inclusion in the FAST-41 program and an EPA Environmental Appeals Board decision upholding UIC permits.
enCore Energy Corp. filed Amendment No. 2 to its shelf registration to include Rule 473(b) language for automatic effectiveness and may offer, from time to time after effectiveness, up to $350,000,000 in Common Shares, Preferred Shares, Debt Securities, Warrants, Subscription Receipts, Share Purchase Contracts, or Units.
Sales may occur via underwriters, dealers, agents, or direct placements, including “at the market offerings,” with the company stating an intended cap of $90.0 million in gross proceeds for any ATM unless a supplement provides otherwise. A prospectus supplement will set specific terms for each issuance. Except as described in an applicable supplement, net proceeds are intended for general corporate purposes, including M&A, debt repayment or refinancing, and capital expenditures.
The Common Shares trade on Nasdaq and the TSX-V under “EU.” As of the date of this prospectus, 187,139,534 Common Shares were issued and outstanding; this is a baseline share count.
enCore Energy Corp. (EU) filed Amendment No. 1 to its shelf registration, providing for the automatic effectiveness of the registration statement 20 days after this amendment under Rule 473(b). The shelf allows the Company to offer and sell, from time to time, up to $350,000,000 aggregate initial offering price of Common Shares, Preferred Shares, Debt Securities, Warrants, Subscription Receipts, Share Purchase Contracts, or Units.
Sales may occur through underwriters, dealers, agents, directly to purchasers, or in at-the-market offerings; the Company intends to cap any at-the-market program at $90.0 million gross proceeds unless otherwise provided in a supplement. Net proceeds will be used for general corporate purposes, including mergers and acquisitions, debt repayment/refinancing, and capital expenditures. Common Shares are listed on Nasdaq and TSX-V under EU; the last reported prices were $2.95 on Nasdaq and CAD$4.08 on TSX-V on October 23, 2025. Common Shares outstanding were 187,139,534 as of the date of the prospectus.
enCore Energy Corp. entered into a Confidential Settlement and General Release Agreement with former CEO William Paul Goranson. So long as he does not revoke the agreement within the prescribed period, the company will pay $922,033.62 within 30 days of the agreement’s effective date. This amount includes a settlement payment, attorneys’ fees, and the cost of COBRA continued coverage from April 2025 to October 2025.
The agreement also provides for subsidization of COBRA premiums for up to 17 months beginning in November 2025, ending earlier if Mr. Goranson becomes eligible for a group health plan with another employer or revokes the agreement. Additional terms include mutual non-disparagement, a release of claims by Mr. Goranson, and reaffirmation of his non-solicitation obligations.
enCore Energy Corp. (EU) director Dennis Stover reported selling 20,000 common shares at $3.5365 on 10/14/2025. Following the transaction, he beneficially owned 468,500 shares, held directly.
The filing was submitted as a single‑reporting‑person Form 4 and signed by /s/ Robert Willette, as attorney‑in‑fact for Dennis Stover on 10/15/2025.
enCore Energy Corp. insider Form 4 shows that Robert J. Willette, the company's Chief Executive Officer and a director, received equity awards on
The awards are standard time‑based compensation tied to multi‑year vesting schedules, aligning senior management incentives with shareholder value over the next several years.
enCore Energy Corp. (EU) reporting person Dain A. McCoig, the Chief Operating Officer and a director, was granted a total of 103,500 restricted stock units (RSUs) on
enCore Energy Corp. (EU) reported a Form 4 showing director Mark Pelizza received 196,499 restricted stock units (RSUs) on October 8, 2025.
Each RSU represents one common share. The award vests in two equal installments: 50% on October 8, 2026 and 50% on October 8, 2027. The filing lists 196,499 derivative securities beneficially owned directly at a price of $0 per unit.
enCore Energy Corp. reported that Executive Chairman William M. Sheriff received equity awards on
enCore Energy Corp. director Nathan Tewalt was granted 145,000 restricted stock units (RSUs) on 10/08/2025. Each RSU represents the contingent right to receive one common share, and the award vests in two equal installments: one-half on 10/08/2026 and one-half on 10/08/2027. The reporting person holds the RSUs directly and the grant was reported on a Form 4 filed by a single reporting person. The Form 4 shows no cash price for the award because these are service-based RSUs rather than open-market purchases.